View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Theme
  2. Macro
  3. Covid-19
June 29, 2020

Dexamethasone and remdesivir could be used in combination

By Victoria Smith

After obtaining a world-first approval by the UK Government, the low-priced and broadly accessible corticosteroid dexamethasone has received notable attention following groundbreaking data indicating that it can lessen Covid-19 deaths among hospitalised patients. While data supporting dexamethasone’s effectiveness seem clear, the magnitude of its advantage remains modest.

GlobalData considers that further studies of dexamethasone are required to bypass the roadblocks faced by hydroxychloroquine, where significant distinctions in results made it challenging to determine the drug’s role in Covid-19 treatment. Read more here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology